Ignite Creation Date:
2024-05-05 @ 11:28 PM
Last Modification Date:
2024-10-26 @ 10:34 AM
Study NCT ID:
NCT01337336
Status:
COMPLETED
Last Update Posted:
2017-05-30
First Post:
2011-04-15
Brief Title:
Chronic Obstructive Pulmonary Disease COPD-Related Outcomes and Costs for Patients on Combination Fluticasone Propionate-Salmeterol Xinafoate 25050mcg Versus Anticholinergics in a COPD-Comorbid DepressionAnxiety Population
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Organization Data
Organization:
GlaxoSmithKline
Class:
INDUSTRY
Study ID:
113902
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
GlaxoSmithKline
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None